Pharmacodynamic Assessment of Ticagrelor vs High Dose Clopidogrel in Patients With ST Elevation Myocardial Infarction Exhibiting High Platelet Reactivity Post Fibrinolysis

Trial Profile

Pharmacodynamic Assessment of Ticagrelor vs High Dose Clopidogrel in Patients With ST Elevation Myocardial Infarction Exhibiting High Platelet Reactivity Post Fibrinolysis

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Oct 2015

At a glance

  • Drugs Ticagrelor (Primary) ; Clopidogrel
  • Indications Myocardial infarction; Stroke; Thrombosis; Venous thromboembolism
  • Focus Pharmacodynamics
  • Most Recent Events

    • 19 Aug 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 01 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top